Medication adherence research: expert perspectives on key HEOR trends for 2026

Tamas Agh; Bijan Borah; Marcia Vervloet; Mickael Hiligsmann

doi:10.1080/14737167.2026.2650160

Medication adherence research: expert perspectives on key HEOR trends for 2026

Tamas Agh^*
, Bijan Borah
, Marcia Vervloet
, Mickael Hiligsmann

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

1 Downloads (Pure)

Original language	English
Pages (from-to)	469-471
Number of pages	3
Journal	Expert Review of Pharmacoeconomics & Outcomes Research
Volume	26
Issue number	4
DOIs	https://doi.org/10.1080/14737167.2026.2650160
Publication status	Published - 1 Mar 2026

Keywords

Medication adherence
medication persistence
adherence trends
research
expert perspective

Access to Document

10.1080/14737167.2026.2650160

Embargoed Document

Full Text
Final published version, 471 KB
Licence: Taverne
Embargo ends: 26/09/2026 00:00 CEST
Request copy

Cite this

@article{994ffb6bd7e54f648d5c7e606b7a0aee,

title = "Medication adherence research: expert perspectives on key HEOR trends for 2026",

keywords = "Medication adherence, medication persistence, adherence trends, research, expert perspective",

author = "Tamas Agh and Bijan Borah and Marcia Vervloet and Mickael Hiligsmann",

year = "2026",

month = mar,

day = "1",

doi = "10.1080/14737167.2026.2650160",

language = "English",

volume = "26",

pages = "469--471",

journal = "Expert Review of Pharmacoeconomics \& Outcomes Research",

issn = "1473-7167",

publisher = "Routledge/Taylor \& Francis Group",

number = "4",

}

TY - JOUR

T1 - Medication adherence research

T2 - expert perspectives on key HEOR trends for 2026

AU - Agh, Tamas

AU - Borah, Bijan

AU - Vervloet, Marcia

AU - Hiligsmann, Mickael

PY - 2026/3/1

Y1 - 2026/3/1

KW - Medication adherence

KW - medication persistence

KW - adherence trends

KW - research

KW - expert perspective

U2 - 10.1080/14737167.2026.2650160

DO - 10.1080/14737167.2026.2650160

M3 - Editorial

SN - 1473-7167

VL - 26

SP - 469

EP - 471

JO - Expert Review of Pharmacoeconomics & Outcomes Research

JF - Expert Review of Pharmacoeconomics & Outcomes Research

IS - 4

ER -